Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Cytomegalovirus Infection

Free Subscription Articles published in J Virol Retrieve available abstracts of 48 articles: HTML format

Single Articles

November 2021
1. YUE Y, Chang WLW, Li J, Nguyen N, et al
   Pathogenesis of wild-type-like rhesus cytomegalovirus strains following oral exposure of immune-competent rhesus macaques.
   J Virol. 2021 Nov 17:JVI0165321. doi: 10.1128/JVI.01653.
   PubMed     Abstract available
   
   
   October 2021
2. RUZIC T, Lisnic VJ, Lucin HM, Rovis TL, et al
   Characterization of M116.1p, a murine cytomegalovirus protein required for efficient infection of mononuclear phagocytes.
   J Virol. 2021 Oct 27:JVI0087621. doi: 10.1128/JVI.00876.
   PubMed     Abstract available
   
   
   September 2021
3. KWON KM, Kim YE, Lee MK, Chung WC, et al
   Human cytomegalovirus UL48 deubiquitinase primarily targets innermost tegument proteins pp150 and itself to regulate their stability and protects virions from inclusion of ubiquitin conjugates.
   J Virol. 2021 Sep 22:JVI0099121. doi: 10.1128/JVI.00991.
   PubMed     Abstract available
   
   
   August 2021
4. DHANWANI R, Dhanda SK, Pham J, Williams GP, et al
   Profiling Human CMV-specific T cell responses reveals novel immunogenic ORFs.
   J Virol. 2021 Aug 11:JVI0094021. doi: 10.1128/JVI.00940.
   PubMed     Abstract available
   
   
   
5. SCHULTZ EP, Yu Q, Stegmann C, Day LZ, et al
   Mutagenesis of Human Cytomegalovirus Glycoprotein L Disproportionately Disrupts gH/gL/gO over gH/gL/pUL128-131.
   J Virol. 2021;95:e0061221.
   PubMed     Abstract available
   
   
   
6. MA J, Bruce K, Stevenson PG, Farrell HE, et al
   Murine Cytomegalovirus MCK-2 Facilitates In Vivo Infection Transfer from Dendritic Cells to Salivary Gland Acinar Cells.
   J Virol. 2021;95:e0069321.
   PubMed     Abstract available
   
   
   
7. LAU B, Kerr K, Camiolo S, Nightingale K, et al
   Human cytomegalovirus RNA2.7 is required for upregulating multiple cellular genes to promote cell motility and viral spread late in lytic infection.
   J Virol. 2021 Aug 4:JVI0069821. doi: 10.1128/JVI.00698.
   PubMed     Abstract available
   
   
   July 2021
8. SUFIAWATI I, Herrera R, Mayer W, Cai X, et al
   Human immunodeficiency virus and human cytomegalovirus coinfection of infant tonsil epithelium may synergistically promote both HIV-1 and HCMV spread and infection.
   J Virol. 2021 Jul 7:JVI0092121. doi: 10.1128/JVI.00921.
   PubMed     Abstract available
   
   
   June 2021
9. FUREY C, Astar H, Walsh D
   Human cytomegalovirus exploits TACC3 to control microtubule dynamics and late stages of infection.
   J Virol. 2021 Jun 30:JVI0082121. doi: 10.1128/JVI.00821.
   PubMed     Abstract available
   
   
   
10. THOMAS M, Kropff B, Schneider A, Winkler TH, et al
    A novel strain-specific neutralizing epitope on glycoprotein H of Human Cytomegalovirus.
    J Virol. 2021 Jun 23:JVI0065721. doi: 10.1128/JVI.00657.
    PubMed     Abstract available
    
    
    
11. ALSULAMI K, Bolastig N, Dupuy FP, Mabanga T, et al
    Influence of NKG2C Genotypes on HIV Susceptibility and Viral Load Set Point.
    J Virol. 2021 Jun 2:JVI0041721. doi: 10.1128/JVI.00417.
    PubMed     Abstract available
    
    
    May 2021
12. SIDDIQUEY MNA, Schultz EP, Yu Q, Amendola D, et al
    The human cytomegalovirus protein UL116 interacts with the viral ER resident glycoprotein UL148 and promotes the incorporation of gH/gL complexes into virions.
    J Virol. 2021 May 19. pii: JVI.02207-20. doi: 10.1128/JVI.02207.
    PubMed     Abstract available
    
    
    
13. WALTER M, Perrone R, Verdin E
    Targeting conserved sequences circumvents the evolution of resistance in a viral gene drive against human cytomegalovirus.
    J Virol. 2021 May 19. pii: JVI.00802-21. doi: 10.1128/JVI.00802.
    PubMed     Abstract available
    
    
    April 2021
14. MONAGHAN M, Munger J
    Contributions of the Human Cytomegalovirus UL30-Associated Open Reading Frames to Infection.
    J Virol. 2021;95.
    PubMed     Abstract available
    
    
    March 2021
15. MOMTAZ S, Molina B, Mlera L, Goodrum F, et al
    Cell type-specific biogenesis of novel vesicles containing viral products in human cytomegalovirus infection.
    J Virol. 2021 Mar 24. pii: JVI.02358-20. doi: 10.1128/JVI.02358.
    PubMed     Abstract available
    
    
    
16. FORTE E, Ayaloglu Butun F, Marinaccio C, Schipma MJ, et al
    Epigenetic reprogramming of host and viral genes by Human Cytomegalovirus infection in Kasumi-3 myeloid progenitor cells at early times post-infection.
    J Virol. 2021 Mar 17. pii: JVI.00183-21. doi: 10.1128/JVI.00183.
    PubMed     Abstract available
    
    
    
17. CHOI KY, El-Hamdi N, Hornig J, McGregor A, et al
    Guinea pig cytomegalovirus protective T cell antigen GP83 is a functional pp65 homolog for innate immune evasion and pentamer dependent virus tropism.
    J Virol. 2021 Mar 3. pii: JVI.00324-21. doi: 10.1128/JVI.00324.
    PubMed     Abstract available
    
    
    January 2021
18. YANG B, Yao Y, Wu H, Yang H, et al
    Localization of the WD repeat-containing protein 5 to the Virion Assembly Compartment Facilitates Human Cytomegalovirus Assembly.
    J Virol. 2021 Jan 27. pii: JVI.02101-20. doi: 10.1128/JVI.02101.
    PubMed     Abstract available
    
    
    
19. CRAWFORD LB, Hancock MH, Struthers HM, Streblow DN, et al
    CD34(+) Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.
    J Virol. 2021;95.
    PubMed     Abstract available
    
    
    December 2020
20. KONIG P, Svrlanska A, Read C, Feichtinger S, et al
    The autophagy-initiating protein kinase ULK1 phosphorylates human cytomegalovirus tegument protein pp28 and regulates efficient virus release.
    J Virol. 2020 Dec 16. pii: JVI.02346-20. doi: 10.1128/JVI.02346.
    PubMed     Abstract available
    
    
    
21. DUNN DM, Rodriguez-Sanchez I, Schafer X, Munger J, et al
    Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection.
    J Virol. 2020 Dec 2. pii: JVI.01321-20. doi: 10.1128/JVI.01321.
    PubMed     Abstract available
    
    
    November 2020
22. KUAN MI, Jaeger HK, Balemba OB, O'Dowd JM, et al
    Human cytomegalovirus interactions with the basement membrane protein nidogen 1.
    J Virol. 2020 Nov 11. pii: JVI.01506-20. doi: 10.1128/JVI.01506.
    PubMed     Abstract available
    
    
    September 2020
23. LLOYD MG, Smith NA, Tighe M, Travis KL, et al
    A novel human skin tissue model to study varicella zoster virus and human cytomegalovirus.
    J Virol. 2020 Sep 2. pii: JVI.01082-20. doi: 10.1128/JVI.01082.
    PubMed     Abstract available
    
    
    
24. ALTMAN AM, Miller MJ, Mahmud J, Smith NA, et al
    Human Cytomegalovirus-Induced Autophagy Prevents Necroptosis Of Infected Monocytes.
    J Virol. 2020 Sep 2. pii: JVI.01022-20. doi: 10.1128/JVI.01022.
    PubMed     Abstract available
    
    
    August 2020
25. REDWOOD AJ, Masters LL, Chan B, Leary S, et al
    Repair of an attenuated low passage murine cytomegalovirus bacterial artificial chromosome identifies a novel spliced gene essential for salivary gland tropism.
    J Virol. 2020 Aug 26. pii: JVI.01456-20. doi: 10.1128/JVI.01456.
    PubMed     Abstract available
    
    
    July 2020
26. ALFI O, From I, Yakirevitch A, Drendel M, et al
    Human Nasal Turbinate Tissues in Organ Culture as a Model for Human Cytomegalovirus Infection at the Mucosal Entry Site.
    J Virol. 2020 Jul 29. pii: JVI.01258-20. doi: 10.1128/JVI.01258.
    PubMed     Abstract available
    
    
    
27. KUTLE I, Szymanska-de Wijs KM, Bogdanow B, Cuvalo B, et al
    Murine cytomegalovirus M25 proteins sequester the tumor suppressor protein p53 in nuclear accumulations.
    J Virol. 2020 Jul 29. pii: JVI.00574-20. doi: 10.1128/JVI.00574.
    PubMed     Abstract available
    
    
    
28. CHAILLON A, Nakazawa M, Rawlings SA, Curtin G, et al
    Subclinical CMV and EBV Shedding is associated with increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.
    J Virol. 2020 Jul 8. pii: JVI.00927-20. doi: 10.1128/JVI.00927.
    PubMed     Abstract available
    
    
    
29. REUTER N, Kropff B, Schneiderbanger JK, Alt M, et al
    Cell fusion induced by a fusion-active form of human cytomegalovirus glycoprotein B is inhibited by antibodies directed at AD-5 in the ectodomain of gB.
    J Virol. 2020 Jul 8. pii: JVI.01276-20. doi: 10.1128/JVI.01276.
    PubMed     Abstract available
    
    
    
30. KUMAR R, Cruz L, Sandhu PK, Buchkovich NJ, et al
    UL88 Mediates the Incorporation of a Subset of Proteins into the Virion Tegument.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    June 2020
31. NUKUI M, Roche KL, Jia J, Fox PL, et al
    Protein S-nitrosylation of Human Cytomegalovirus pp71 inhibits its ability to limit STING antiviral responses.
    J Virol. 2020 Jun 24. pii: JVI.00033-20. doi: 10.1128/JVI.00033.
    PubMed     Abstract available
    
    
    
32. SCHULTZ EP, Lanchy JM, Day LZ, Yu Q, et al
    Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
33. STRECK NT, Zhao Y, Sundstrom JM, Buchkovich NJ, et al
    Human Cytomegalovirus Utilizes Extracellular Vesicles to Enhance Virus Spread.
    J Virol. 2020 Jun 10. pii: JVI.00609-20. doi: 10.1128/JVI.00609.
    PubMed     Abstract available
    
    
    
34. MAHMUD J, Miller MJ, Altman AM, Chan GC, et al
    Human Cytomegalovirus Glycoprotein-Initiated Signaling Mediates the Aberrant Activation of Akt.
    J Virol. 2020 Jun 3. pii: JVI.00167-20. doi: 10.1128/JVI.00167.
    PubMed     Abstract available
    
    
    April 2020
35. BRAIT N, Stogerer T, Kalser J, Adler B, et al
    Influence of human cytomegalovirus glycoprotein O polymorphism on the inhibitory effect of soluble forms of trimer- and pentamer-specific entry receptors.
    J Virol. 2020 Apr 29. pii: JVI.00107-20. doi: 10.1128/JVI.00107.
    PubMed     Abstract available
    
    
    
36. LEE MK, Hyeon S, Ahn JH
    Loss of VCP/p97 induced by the human cytomegalovirus transmembrane protein pUL50 and its regulation by a small isoform of pUL50.
    J Virol. 2020 Apr 22. pii: JVI.00110-20. doi: 10.1128/JVI.00110.
    PubMed     Abstract available
    
    
    
37. ZOU HM, Huang ZF, Yang Y, Luo WW, et al
    Human Cytomegalovirus Protein UL94 Targets MITA to Evade Antiviral Immune Response.
    J Virol. 2020 Apr 1. pii: JVI.00022-20. doi: 10.1128/JVI.00022.
    PubMed     Abstract available
    
    
    March 2020
38. THOMAS M, Muller R, Horn G, Bogdanow B, et al
    Phosphosite Analysis of the Cytomegaloviral mRNA Export Factor pUL69 Reveals Serines with Critical Importance for Recruitment of Cellular Proteins Pin1 and UAP56/URH49.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
39. RAK MA, Buehler J, Zeltzer S, Reitsma J, et al
    Erratum for Rak et al., "Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency".
    J Virol. 2020;94.
    PubMed    
    
    
    
40. SANDHU PK, Buchkovich NJ
    Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    February 2020
41. NELSON CS, Jenks JA, Pardi N, Goodwin M, et al
    HCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization.
    J Virol. 2020 Feb 12. pii: JVI.00186-20. doi: 10.1128/JVI.00186.
    PubMed     Abstract available
    
    
    January 2020
42. DAY LZ, Stegmann C, Schultz EP, Lanchy JM, et al
    Polymorphisms in Human Cytomegalovirus gO Exert Epistatic Influences on Cell-Free and Cell-To-Cell Spread, and Antibody Neutralization on gH Epitopes.
    J Virol. 2020 Jan 29. pii: JVI.02051-19. doi: 10.1128/JVI.02051.
    PubMed     Abstract available
    
    
    
43. MURRAY MJ, Bonilla-Medrano NI, Lee QL, Oxenford SJ, et al
    Evasion of a human cytomegalovirus entry inhibitor with potent cysteine reactivity is concomitant with the utilisation of a heparan sulfate proteoglycan independent route of entry.
    J Virol. 2020 Jan 15. pii: JVI.02012-19. doi: 10.1128/JVI.02012.
    PubMed     Abstract available
    
    
    
44. HAN T, Hao H, Sleman SS, Xuan B, et al
    Murine cytomegalovirus protein pM49 interacts with pM95 and is critical for viral late gene expression.
    J Virol. 2020 Jan 2. pii: JVI.01956-19. doi: 10.1128/JVI.01956.
    PubMed     Abstract available
    
    
    December 2019
45. NGUYEN CC, Domma AJ, Zhang H, Kamil JP, et al
    ER reorganization and intracellular retention of CD58 are functionally independent properties of the human cytomegalovirus ER resident glycoprotein UL148.
    J Virol. 2019 Dec 4. pii: JVI.01435-19. doi: 10.1128/JVI.01435.
    PubMed     Abstract available
    
    
    
46. CHIUPPESI F, Nguyen J, Park S, Contreras H, et al
    Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice".
    J Virol. 2019;93.
    PubMed    
    
    
    November 2019
47. COMBS JA, Norton EB, Saifudeen ZR, Honer Zu Bentrup K, et al
    Human Cytomegalovirus Alters Host Cell Mitochondrial Function During Acute Infection.
    J Virol. 2019 Nov 6. pii: JVI.01183-19. doi: 10.1128/JVI.01183.
    PubMed     Abstract available
    
    
    October 2019
48. AGUILAR OA, Sampaio IS, Rahim MMA, Samaniego JD, et al
    Mouse cytomegalovirus m153 protein stabilizes expression of the inhibitory NKR-P1B ligand, Clr-b.
    J Virol. 2019 Oct 9. pii: JVI.01220-19. doi: 10.1128/JVI.01220.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: